ACBM - ACRO BIOMEDICAL CO., LTD.


0.026
0   0%

Share volume: 387
Last Updated: 03-23-2026
Entertainment/Services – Amusement And Recreation: -0.08%

PREVIOUS CLOSE
CHG
CHG%

$0.03
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
58%
Profitability 43%
Dept financing 50%
Liquidity 18%
Performance 85%
Company vs Stock growth
vs
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
-25.71%
1 Year
-25.71%
2 Year
-25.71%
Key data
Stock price
$0.03
P/E Ratio 
0.00
DAY RANGE
$0.03 - $0.10
EPS 
N/A
52 WEEK RANGE
$0.03 - $0.10
52 WEEK CHANGE
-$25.71
MARKET CAP 
1.333 M
YIELD 
N/A
SHARES OUTSTANDING 
60.042 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$387
AVERAGE 30 VOLUME 
$942
Company detail
CEO:
Region: US
Website: acrobiomedicalco.com
Employees: 0
IPO year: 2018
Issue type:
Market: OTCM
Industry: Entertainment/Services – Amusement And Recreation
Sector: Services

Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. It sells cordycepin and cordceps powder, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc.

Recent news